Darragh Duffy Selected Research

Antibodies

1/2023	Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus.
11/2021	Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
1/2021	Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection.
12/2020	Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.
1/2020	Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darragh Duffy Research Topics

Disease

27	Infections 10/2023 - 02/2012
15	COVID-19 05/2024 - 01/2020
13	Inflammation (Inflammations) 10/2023 - 08/2013
9	Tuberculosis (Tuberculoses) 08/2023 - 12/2009
7	Dermatomyositis (Dermatopolymyositis) 01/2023 - 01/2017
6	Neoplasms (Cancer) 10/2023 - 11/2015
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2017
5	Pneumonia (Pneumonitis) 11/2022 - 01/2018
3	Latent Infection 02/2024 - 11/2021
3	Human Influenza (Influenza) 08/2023 - 10/2017
3	Myositis (Idiopathic Inflammatory Myopathies) 11/2022 - 01/2020
3	Virus Diseases (Viral Diseases) 01/2022 - 04/2014
3	HIV Infections (HIV Infection) 01/2021 - 06/2009
3	Chronic Hepatitis C 11/2018 - 10/2014
2	Disease Progression 01/2023 - 01/2021
2	Arthritis (Polyarthritis) 01/2023 - 01/2020
2	Central Nervous System Lupus Vasculitis 01/2023 - 12/2020
2	Cutaneous Lupus Erythematosus 05/2022 - 01/2019
2	Bites and Stings (Sting) 11/2020 - 01/2017
2	Persistent Infection 01/2018 - 01/2015
2	Hepatitis C 01/2015 - 10/2014
2	Vaccinia 06/2009 - 05/2009
1	VEXAS syndrome 01/2024
1	Ichthyosis (Xeroderma) 10/2023
1	Arthralgia (Joint Pain) 10/2023
1	Diarrhea 10/2023
1	Atopic Dermatitis (Atopic Eczema) 10/2023
1	Hypersensitivity (Allergy) 10/2023
1	Central Nervous System Diseases (CNS Diseases) 01/2023
1	Bone Resorption 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Myasthenia Gravis 01/2023
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2023
1	Osteonecrosis (Kienbock's Disease) 01/2023
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2023
1	Rheumatoid Arthritis 06/2022
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022
1	IgA Deficiency 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Primary Immunodeficiency Diseases 01/2022
1	Dysbiosis 01/2022
1	Acute-Phase Reaction 01/2022
1	COVID-19 related pediatric multisystem inflammatory disease 10/2021
1	Myocarditis (Carditis) 10/2021
1	Necrosis 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021

Drug/Important Bio-Agent (IBA)

20	InterferonsIBA 11/2022 - 01/2015
15	CytokinesIBA 05/2024 - 01/2017
15	Interferon Type IIBA 01/2023 - 01/2018
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2014
11	AutoantibodiesIBA 01/2023 - 01/2018
10	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2014
8	VaccinesIBA 08/2023 - 06/2009
6	AntigensIBA 01/2022 - 06/2009
5	AntibodiesIBA 01/2023 - 01/2020
3	Chemokine ReceptorsIBA 01/2024 - 02/2012
3	EnzymesIBA 01/2024 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
3	ChemokinesIBA 10/2021 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2018
3	Interferon-alpha (Interferon Alfa)IBA 12/2020 - 01/2019
3	ruxolitinibIBA 01/2020 - 01/2018
2	InflammasomesIBA 01/2024 - 05/2022
2	Neutralizing AntibodiesIBA 10/2023 - 11/2021
2	Histamine (Histamine Dihydrochloride)FDA Link 10/2023 - 01/2023
2	Cholinergic ReceptorsIBA 01/2023 - 01/2020
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2018
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 04/2014
2	Interleukin-1 (Interleukin 1)IBA 01/2022 - 01/2020
2	Janus Kinase InhibitorsIBA 12/2021 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 10/2020 - 01/2018
2	Chemotactic FactorsIBA 07/2019 - 08/2013
2	Immunoglobulin E (IgE)IBA 07/2019 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 01/2015
2	Chemokine CXCL10IBA 01/2019 - 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2024
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2024
1	Interleukin-18 (Interleukin 18)IBA 01/2024
1	baricitinibIBA 10/2023
1	Poly I-CIBA 08/2023
1	SuperantigensIBA 08/2023
1	OxylipinsIBA 08/2023
1	Enterotoxins (Enterotoxin)IBA 08/2023
1	CollagenIBA 01/2023
1	Nucleic AcidsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Methotrexate (Mexate)FDA LinkGeneric 11/2022
1	LectinsIBA 01/2022
1	SolutionsIBA 11/2021
1	AcidsIBA 01/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021
1	Viral RNAIBA 01/2021
1	Interferon-betaIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2015
1	Hematopoietic Stem Cell Transplantation 01/2022